Consensus Walvax Biotechnology Co., Ltd.

Equities

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 29/04/2024 am IST			5-day change	1st Jan Change
14.84 ^CNY	+3.56%		+3.85%	-36.88%

26/04	Walvax Biotechnology's Profit Drops 92%, Operating Income Slids 28% in Q1 2024	MT
25/04	Walvax Biotechnology's Unit to End COVID-19 Vaccine Trial	MT

125a6.JCJ_sDI8-9_ATLyIZY7QuBNno_OBYtR9i7rx3Il-e4k.V1Iz0x9VzO_2PvfZXNuczkxU6IrgVrIo5fyn7usLVt5xYxvpBmaTnpB1-Q~be2eebac069777fa781000ed949267a3

Walvax Biotechnology Scraps Plan to Issue Convertible Bonds	01/04	MT
China's potential mRNA COVID vaccine weaker against Omicron-study	16/22/16	RE

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

14.84 CNY

Average target price

20 CNY

Spread / Average Target

+34.77%

High Price Target

25 CNY

Spread / Highest target

+68.46%

Low Price Target

15 CNY

Spread / Lowest Target

+1.08%

Trading Rating

Investor Rating

ESG Refinitiv

C+